These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11105935)

  • 21. Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.
    Vickers SP; Easton N; Webster LJ; Wyatt A; Bickerdike MJ; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 May; 167(3):274-80. PubMed ID: 12690422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Brain Res; 2000 May; 865(1):85-90. PubMed ID: 10814735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT
    Faton S; Tassin JP; Duranton F; Bagnol D; Lajoix AD
    Behav Brain Res; 2018 Jul; 347():234-241. PubMed ID: 29555337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553.
    Millan MJ; Girardon S; Bervoets K
    Neuropharmacology; 1997; 36(4-5):743-5. PubMed ID: 9225301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice.
    Vickers SP; Clifton PG; Dourish CT; Tecott LH
    Psychopharmacology (Berl); 1999 Apr; 143(3):309-14. PubMed ID: 10353435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.
    Kennett G; Lightowler S; Trail B; Bright F; Bromidge S
    Eur J Pharmacol; 2000 Jan; 387(2):197-204. PubMed ID: 10650160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.
    Grottick AJ; Corrigall WA; Higgins GA
    Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.
    Bezzina G; Body S; Cheung TH; Hampson CL; Bradshaw CM; Glennon JC; Szabadi E
    Psychopharmacology (Berl); 2015 Feb; 232(4):699-711. PubMed ID: 25134499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK; Evans DC
    Neuropharmacology; 2002 Feb; 42(2):162-9. PubMed ID: 11804612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT2C receptor agonists as potential drugs for the treatment of obesity.
    Bickerdike MJ
    Curr Top Med Chem; 2003; 3(8):885-97. PubMed ID: 12678838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors.
    Di Matteo V; Di Mascio M; Di Giovanni G; Esposito E
    Psychopharmacology (Berl); 2000 May; 150(1):45-51. PubMed ID: 10867975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.
    Gibson EL; Kennedy AJ; Curzon G
    Eur J Pharmacol; 1993 Sep; 242(1):83-90. PubMed ID: 8223940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior.
    Grottick AJ; Fletcher PJ; Higgins GA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1183-91. PubMed ID: 11082456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats.
    López-Alonso VE; Mancilla-Díaz JM; Rito-Domingo M; González-Hernández B; Escartín-Pérez RE
    Neurosci Lett; 2007 Apr; 416(3):285-8. PubMed ID: 17324511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the rat.
    Schreiber R; De Vry J
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):441-9. PubMed ID: 11999893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist.
    Higgs S; Cooper AJ; Barnes NM
    Psychopharmacology (Berl); 2011 Apr; 214(4):941-7. PubMed ID: 21140257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Nakai K; Nakae A; Oba S; Mashimo T; Ueda K
    Eur J Pain; 2010 Nov; 14(10):999-1006. PubMed ID: 20488736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat.
    Grignaschi G; Samanin R
    Eur J Pharmacol; 1992 Mar; 212(2-3):287-9. PubMed ID: 1601071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.
    Overstreet DH; Knapp DJ; Angel RA; Navarro M; Breese GR
    Psychopharmacology (Berl); 2006 Jul; 187(1):1-12. PubMed ID: 16767411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.